MOROZZI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.923
EU - Europa 3.693
AS - Asia 802
SA - Sud America 47
AF - Africa 29
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 10.510
Nazione #
US - Stati Uniti d'America 5.900
GB - Regno Unito 890
IE - Irlanda 651
CN - Cina 577
UA - Ucraina 435
SE - Svezia 408
IT - Italia 366
DE - Germania 258
RU - Federazione Russa 252
FR - Francia 214
SG - Singapore 144
FI - Finlandia 113
BR - Brasile 43
CI - Costa d'Avorio 26
BE - Belgio 25
ES - Italia 23
KR - Corea 17
NL - Olanda 17
CA - Canada 16
VN - Vietnam 15
IN - India 12
CZ - Repubblica Ceca 10
TR - Turchia 9
AT - Austria 8
IR - Iran 8
AU - Australia 6
EU - Europa 6
HK - Hong Kong 6
GR - Grecia 4
RO - Romania 4
DK - Danimarca 3
MX - Messico 3
PK - Pakistan 3
PL - Polonia 3
BG - Bulgaria 2
CH - Svizzera 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GS - Georgia del Sud e Isole Sandwich Australi 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
MA - Marocco 1
MC - Monaco 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.510
Città #
Menlo Park 1.653
Southend 804
Dublin 638
Fairfield 528
Chandler 400
Ashburn 364
Jacksonville 350
Santa Clara 298
Woodbridge 271
Ann Arbor 231
Wilmington 220
Seattle 210
Cambridge 181
Houston 170
Beijing 143
Princeton 120
Nanjing 117
Siena 96
Singapore 91
New York 78
San Diego 57
Boardman 53
Nanchang 48
Helsinki 43
San Mateo 41
Dearborn 35
Shenyang 29
Hebei 27
Abidjan 26
Brussels 24
Moscow 24
Shanghai 24
Tianjin 22
Málaga 21
Kunming 20
Venezia 19
Falls Church 18
Düsseldorf 16
Jiaxing 16
London 16
Milan 16
Rome 16
Changsha 15
Dong Ket 15
Jinan 14
Council Bluffs 12
Lancaster 12
Mestre 12
Ningbo 12
Zhengzhou 12
Los Angeles 11
San Francisco 11
Toronto 11
Brno 10
Guangzhou 10
Munich 8
Norwalk 8
Redwood City 8
Roverbella 8
Washington 8
Vienna 7
Changchun 6
Hangzhou 6
Padova 6
Feira de Santana 5
Florence 5
Izmir 5
Lanzhou 5
Piscataway 5
Frankfurt am Main 4
Genoa 4
Hanover 4
Macerata 4
Mantova 4
Rio de Janeiro 4
Taizhou 4
Ancona 3
Auburn Hills 3
Bangalore 3
Bari 3
Cecina 3
Central 3
Chicago 3
Chiswick 3
Crotone 3
Hyderabad 3
Monreale 3
Nürnberg 3
Ottawa 3
Sacramento 3
São Paulo 3
Verdellino 3
Verona 3
Warsaw 3
Amsterdam 2
Athens 2
Aversa 2
Bisceglie 2
Boston 2
Brescia 2
Totale 7.915
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 295
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 258
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 257
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 248
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 220
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 196
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 187
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 187
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 182
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 179
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 172
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 171
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 170
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 169
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 166
Antinuclear Human Autoantibodies as Markers in Nicotiana Tabacum Pollen Tubes 166
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis 163
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 160
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 158
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 158
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study 157
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 156
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 154
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study 153
Serologic profile and mortality rates of scleroderma renal crisis in Italy 152
Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis 152
Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis. 151
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 150
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 146
Ruolo degli autoanticorpi nella diagnosi della colangite sclerosante primitiva 146
Esame del liquido sinoviale 144
Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? 143
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 141
Chromosome aberrations in Raynaud's phenomenon 141
Usefulness of the determination of C reactive protein and other acute phase proteins in rheumatoid arthritis [Utilità del dosaggio della proteina C reattiva e di altre proteine della fase acuta nell'artrite reumatoide] 139
Thiopurine methyltransferase activity in the erythrocytes of adults and children: and HPLC-linked assay 137
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 137
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 136
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 136
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 136
Modification of DNA patterns in plasma and nucleated blood cells from systemic sclerosis patients 135
Semeiotica di laboratorio delle malattie reumatiche 133
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 133
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohoert of SLE patients 131
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 129
Comportamento delle purine plasmatiche e urinarie dopo dieta apurinica in soggetti normali e gottosi. 127
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 127
Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis 127
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 126
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 121
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies 120
null 117
Epidemiologic study about hyperuricemia's prevalence on an unselected champion of subjects, in a village of Siena's province 117
Clearance of oxypurines and uric acid in gouty patients [Clearance delle ossipurine e dell'acido urico in soggetti gottosi] 115
Immunogenetics of the antiphospholipid syndrome 115
Lessons from the "Euro-Lupus Cohort" 113
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 113
Comparison of different methods for the detection ofanti-Ro/SSA antibodies in connective tissue diseases. 113
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) 110
Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations [Varianti alleliche dei DPB1, DQA1, DQB1, DRB1 e artite reumatoide: ulteriori considerazioni genetiche e statistiche] 110
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 108
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus : correlation with clinical and autoantibody subsets 107
L'elettroforesi bidimensionale su gel di poliacrilamide nello studio dei profili proteici sierici nell'artrite reumatoide 105
Is two dimensional polyacrilamide gel electrophoresis a usful technique for the study of serum protein profiles in rheumatoid arthritis 103
Human serum recognizes components of plant cells: New research perspectives [Sieri umani riconoscono componenti di cellule vegetali: Nuove prospettive di ricerca] 101
Evaluation of the clinical therapeutic response to oral gold salts in patients with rheumatoid arthritis 100
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 99
null 89
Effect of local corticosteroid injection in carpal tunnel syndrome: Clinical and electrophysiological aspects [Efficacia del trattamento con cortisonoci nella sindrome del tunnel carpale idiopatica: studio clinico e neurofisiologico] 88
In vitro study on the possible inflammatory mechanism of ferrous ions: effect on the production of oxygen free radicals [Studi in vitro sul possibile meccanismo flogogeno degli ioni ferro: azione sulla produzione di radicali liberi dell'ossigeno] 86
Immunogenetics of systemic lupus erythematosus: The contribution of DRB3 and DQB1 alleles [Immunogenetica del lupus eritematoso sistemico: il ruolo degli alleli DRB3 e DQB1] 75
Lesch-Nyhan syndrome: Observations on a clinical case [La sindrome di Lesch-Nyhan: osservazione di un caso clinico] 75
null 69
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. 52
Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015 46
PARP activity and NAD concentration in PMC from patients affected by systemic sclerosis and lupus erythematosus 28
Il test ANA-reflex.The ANA-reflex test. 24
Antibodies to the lens and cornea in anti-DFS70-positive subjects 6
A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases. 4
Rheumatoid factor isotypes in patients with erosive osteoarthritis of the hand. 3
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. 2
Totale 10.571
Categoria #
all - tutte 30.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020680 0 0 0 0 0 0 0 231 113 170 61 105
2020/20211.116 70 118 25 117 62 149 51 174 127 65 99 59
2021/2022897 59 108 51 108 39 20 41 38 31 102 73 227
2022/20231.406 86 122 203 205 146 270 16 117 145 25 56 15
2023/20241.062 41 22 86 93 41 299 336 24 12 9 11 88
2024/2025955 35 112 174 102 301 109 44 78 0 0 0 0
Totale 10.571